lundi 7 octobre 2019

Onco Actu du 7 octobre 2019


1. BIOLOGIE



Study: Aggressive Breast Cancers Store Large Amounts of Energy, Which Enables It to Spread [University of Michigan]











1.3 PRIX NOBEL



The Nobel Prize in Physiology or Medicine 2019 [Nobel]










1.4 BIOLOGIE - TECHNOS, MODÈLES



Researchers Make It Possible for Ultrasound to Reveal Gene Expression in the Body [Caltech]











2. ETIOLOGIE



N-Acetyl Cysteine: A Warning Shot [In The Pipeline]










2.11 ETIOLOGIE - ALIMENTATION



Don’t put red, processed meat back on the menu: Cancer and dietary experts dispute controversial directive [The Cancer Letter]











Guyatt: Existing dietary guidelines for red and processed meat are based on slim evidence and are paternalistic [The Cancer Letter]










Scientist Who Discredited Meat Guidelines Didn’t Report Past Food Industry Ties [NY Times]











3.1 PRÉVENTION - TABAC



Altria launches Iqos tobacco device in US, and the timing couldn’t be better [CNBC]











3.1.1 PRÉVENTION - TABAC - E-CIGS



Statement on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses [FDA]










So You Want to Quit Vaping? No One Actually Knows How [Wired]











U.S. judge keeps intact Massachusetts' toughest-in-nation vaping ban [Reuters]











5. TRAITEMENTS



‘It’s really a horrific situation’: What one doctor thinks about drug shortages‚ and how to solve them [STAT]










5.1 TRAITEMENTS - PRÉ-CLINIQUE



Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment [STAT]











New evolution-busting drug overcomes resistance in aggressive breast cancers [Institute of Cancer Research]











5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES



Arcellx raises $85M to take anti-BCMA cell therapy into humans [Fierce Biotech]











5.2 PHARMA



J&J steps forward in PARP prostate-cancer race with FDA ‘breakthrough’ for Zejula [Fierce Pharma]











Moffitt Cancer Center Launches Immunotherapy Contract Research Organization [Moffitt Cancer Center]











5.4 TRAITEMENTS - ECONOMIE



Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report [Fierce Pharma]











King Keytruda: Merck's PD-1 star scores #1 position and $22B+ prediction in another top 10 blockbuster list for 2025 [EndPoints]











6. LUTTE CONTRE LES CANCERS



Why the Women Most Likely to Die of Breast Cancer Have Gotten the Least Attention [TIME]